3r7r | pdb_00003r7r
From Proteopedia
Structure-based design of thienobenzoxepin inhibitors of PI3-Kinase
| ||||||||||||
Structural highlights
Publication Abstract from PubMedStarting from thienobenzopyran HTS hit 1, co-crystallization, molecular modeling and metabolic analysis were used to design potent and metabolically stable inhibitors of PI3-kinase. Compound 15 demonstrated PI3K pathway suppression in a mouse MCF7 xenograft model. Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.,Staben ST, Siu M, Goldsmith R, Olivero AG, Do S, Burdick DJ, Heffron TP, Dotson J, Sutherlin DP, Zhu BY, Tsui V, Le H, Lee L, Lesnick J, Lewis C, Murray JM, Nonomiya J, Pang J, Prior WW, Salphati L, Rouge L, Sampath D, Sideris S, Wiesmann C, Wu P Bioorg Med Chem Lett. 2011 Jul 1;21(13):4054-8. Epub 2011 May 13. PMID:21636270[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
| ||||||||||||||||||||||||
This page was last modified 12:32, 9 December 2014.